The Place of Corticosteroids in Migraine Attack Management: a 65-year Systematic Review with Pooled Analysis and Critical Appraisal (S23.007)

CONCLUSIONS: Our literature review suggests that with corticosteroid treatment, recurrent headaches become milder than pretreated headaches and later respond to nonsteroidal therapy. Single-dose intravenous dexamethasone is a reasonable option for managing resistant, severe, or prolonged migraine attacks.Disclosure: Dr. Woldeamanuel has nothing to disclose. Dr. Rapoport has received personal compensation for activities with Pfizer Inc, Endo Pharmaceuticals, Nupathe, and MAP Pharmaceuticals. Dr. Cowan has received personal compensation for activities with Allergan, Inc., MAP Pharmaceuticals, Nautilus Neurosciences, and Nupathe.
Source: Neurology - Category: Neurology Authors: Tags: Headache: Epidemiology and Clinical Source Type: research